Compared to primary GBM tissues, IHC and WB results showed that SOCS5 expression level significantly increased in recurrent GBM after the initial surgery and TMZ chemotherapy (Figure 2(a,b)). This evidence concerns the gene SOCS5 and glioblastoma.